Although women are often thought of as the drivers for healthcare in their families, many face financial and logistical barriers to obtaining healthcare for themselves, according to a new study by the Kaiser Family Foundation.
Although women are often thought of as the drivers for healthcare in their families, many face financial and logistical barriers to obtaining healthcare for themselves, according to a new study by the Kaiser Family Foundation.
The study found that the cost of healthcare caused 26% of women to delay or go without treatment in the past year. Uninsured women face even more issues with cost, with 65% reporting delaying or forgoing treatment because they couldn’t afford it. Even women with insurance struggle with the cost of healthcare-16% of women with private insurance and 35% of women with Medicaid say costs stop them from receiving treatment.
Finding time to get to the doctor’s office is even more of a challenge for women. Twenty-three percent of women surveyed say they don’t have the time to go to the doctor, and almost 20% cannot take off time at work. Nearly a quarter of low-income women count burdens such as transportation and childcare as reasons that they don’t get healthcare.
Wellness and preventive-care visits to physicians are the gateway to care for many patients, with 82% of women reporting having well-woman visits. However, fewer women say that their visit includes questions about other aspects of their health. In the past 3 years, 70% of the women surveyed said their physicians talked to them about nutrition and diet, and less than half were asked about substance abuse, smoking, and mental health.
The study’s authors suggest that because many women only see gynecologists for reproductive care, providers need to work harder at filling the gaps in wellness and preventive coverage.
“A deeper focus on the content of well woman visits, along with patient education, may be needed to broaden use of clinical preventive services for women,” the study’s authors said.
The survey was conducted with nearly 3000 women at the end of 2013, before the first phase of Affordable Care Act’s (ACA) individual mandate and Medicaid expansion were implemented. However, many other aspects of ACA had already been in play, including expansion of preventive, wellness, and maternity coverage. The authors say that the study will serve as a measure of the effectiveness of ACA provisions to fill coverage gaps.
“In the coming years, millions of uninsured women could gain access to coverage that includes a wide range of benefits that are important to their care,” the study’s authors said.
Salganicoff A, Ranji U, Beamesderfer A, Kurani N. Women and health care in the early years of the ACA: key findings from the 2013 Kaiser Women’s Health Survey. http://kff.org/womens-health-policy/report/women-and-health-care-in-the-early-years-of-the-aca-key-findings-from-the-2013-kaiser-womens-health-survey/.
Phase 2b safety data for Sildenafil Cream against FSAD reported
August 26th 2024In a recent study published in The Journal of Sexual Medicine, Sildenafil Cream, 3.6% was indicated as safe and well-tolerated for use against female sexual arousal disorder in healthy premenopausal women.
Read More
Study: Pelvic floor dilator reduces pelvic floor muscle injury during vaginal delivery
August 6th 2024A new pilot study published in the International Urogynecology Journal found that Materna Medical’s Prep Device, a pelvic floor dilator, reduced full levator ani muscle avulsion during vaginal delivery in first-time mothers.
Read More
Similar success rates for synthetic and nonsynthetic slings in SUI treatment
July 31st 2024A study found that both synthetic and nonsynthetic slings show similar success rates for treating stress urinary incontinence in women, with synthetic slings demonstrating improved operative outcomes and reduced complications.
Read More
First hysterectomy using miniaturized MIRA Surgical System performed
July 30th 2024Virtual Incision Corporation has announced the successful performance of the first benign hysterectomy using their miniaturized robotic-assisted surgery device, MIRA, in a clinical trial assessing its safety and efficacy.
Read More